108 related articles for article (PubMed ID: 11457435)
1. Multiple ligand interaction of alpha-synuclein produced various forms of protein aggregates in the presence of Abeta25-35, copper, and eosin.
Kim YS; Lee D; Lee EK; Sung JY; Chung KC; Kim J; Paik SR
Brain Res; 2001 Jul; 908(1):93-8. PubMed ID: 11457435
[TBL] [Abstract][Full Text] [Related]
2. Eosin interaction of alpha-synuclein leading to protein self-oligomerization.
Shin HJ; Lee EK; Lee JH; Lee D; Chang CS; Kim YS; Paik SR
Biochim Biophys Acta; 2000 Aug; 1481(1):139-46. PubMed ID: 11004584
[TBL] [Abstract][Full Text] [Related]
3. Copper(II)-induced self-oligomerization of alpha-synuclein.
Paik SR; Shin HJ; Lee JH; Chang CS; Kim J
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):821-8. PubMed ID: 10359669
[TBL] [Abstract][Full Text] [Related]
4. Phthalocyanine tetrasulfonates affect the amyloid formation and cytotoxicity of alpha-synuclein.
Lee EN; Cho HJ; Lee CH; Lee D; Chung KC; Paik SR
Biochemistry; 2004 Mar; 43(12):3704-15. PubMed ID: 15035641
[TBL] [Abstract][Full Text] [Related]
5. Beta-Synuclein-derived peptides with neuroprotective activity: an alternative treatment of neurodegenerative disorders?
Windisch M; Hutter-Paier B; Schreiner E; Wronski R
J Mol Neurosci; 2004; 24(1):155-65. PubMed ID: 15314265
[TBL] [Abstract][Full Text] [Related]
6. Dependence of alpha-synuclein aggregate morphology on solution conditions.
Hoyer W; Antony T; Cherny D; Heim G; Jovin TM; Subramaniam V
J Mol Biol; 2002 Sep; 322(2):383-93. PubMed ID: 12217698
[TBL] [Abstract][Full Text] [Related]
7. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
Conway KA; Harper JD; Lansbury PT
Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204
[TBL] [Abstract][Full Text] [Related]
8. Self-oligomerization and protein aggregation of alpha-synuclein in the presence of Coomassie Brilliant Blue.
Lee D; Lee EK; Lee JH; Chang CS; Paik SR
Eur J Biochem; 2001 Jan; 268(2):295-301. PubMed ID: 11168363
[TBL] [Abstract][Full Text] [Related]
9. Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide.
Paik SR; Shin HJ; Lee JH
Arch Biochem Biophys; 2000 Jun; 378(2):269-77. PubMed ID: 10860544
[TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein: its biological function and role in neurodegenerative diseases.
Kaplan B; Ratner V; Haas E
J Mol Neurosci; 2003 Apr; 20(2):83-92. PubMed ID: 12794302
[TBL] [Abstract][Full Text] [Related]
11. Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments.
Emadi S; Liu R; Yuan B; Schulz P; McAllister C; Lyubchenko Y; Messer A; Sierks MR
Biochemistry; 2004 Mar; 43(10):2871-8. PubMed ID: 15005622
[TBL] [Abstract][Full Text] [Related]
12. Glial cell death induced by overexpression of alpha-synuclein.
Stefanova N; Klimaschewski L; Poewe W; Wenning GK; Reindl M
J Neurosci Res; 2001 Sep; 65(5):432-8. PubMed ID: 11536327
[TBL] [Abstract][Full Text] [Related]
13. Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins.
El-Agnaf OM; Irvine GB
J Struct Biol; 2000 Jun; 130(2-3):300-9. PubMed ID: 10940234
[TBL] [Abstract][Full Text] [Related]
14. Insights into the thermodynamics of copper association with amyloid-β, α-synuclein and prion proteins.
Hong L; Simon JD
Metallomics; 2011 Mar; 3(3):262-6. PubMed ID: 21116546
[TBL] [Abstract][Full Text] [Related]
15. Novel Benzothiazole Derivatives as Fluorescent Probes for Detection of β-Amyloid and α-Synuclein Aggregates.
Watanabe H; Ono M; Ariyoshi T; Katayanagi R; Saji H
ACS Chem Neurosci; 2017 Aug; 8(8):1656-1662. PubMed ID: 28467708
[TBL] [Abstract][Full Text] [Related]
16. Membrane binding and self-association of alpha-synucleins.
Narayanan V; Scarlata S
Biochemistry; 2001 Aug; 40(33):9927-34. PubMed ID: 11502187
[TBL] [Abstract][Full Text] [Related]
17. Residues in the synuclein consensus motif of the alpha-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid beta A4 peptide.
Jensen PH; Sørensen ES; Petersen TE; Gliemann J; Rasmussen LK
Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):91-4. PubMed ID: 7646476
[TBL] [Abstract][Full Text] [Related]
18. Following the leader: fibrillization of alpha-synuclein and tau.
Frasier M; Wolozin B
Exp Neurol; 2004 Jun; 187(2):235-9. PubMed ID: 15144849
[No Abstract] [Full Text] [Related]
19. Expression of beta-synuclein in normal human astrocytes.
Tanji K; Mori F; Nakajo S; Imaizumi T; Yoshida H; Hirabayashi T; Yoshimoto M; Satoh K; Takahashi H; Wakabayashi K
Neuroreport; 2001 Sep; 12(13):2845-8. PubMed ID: 11588588
[TBL] [Abstract][Full Text] [Related]
20. A comparison of amyloid fibrillogenesis using the novel fluorescent compound K114.
Crystal AS; Giasson BI; Crowe A; Kung MP; Zhuang ZP; Trojanowski JQ; Lee VM
J Neurochem; 2003 Sep; 86(6):1359-68. PubMed ID: 12950445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
